Molina Healthcare

Molina Healthcare’s pricing power score of 45 out of 100 is largely influenced by the nature of its core business in government-sponsored healthcare programs. In Medicaid and Medicare Advantage markets, pricing is primarily determined by state and federal reimbursement rates and competitive bidding processes, rather than direct consumer influence.

This regulatory environment inherently limits the company's ability to unilaterally raise prices. While Molina's substantial scale and established provider networks can offer some leverage in negotiating better rates with healthcare providers, this is distinct from direct pricing power over the end payer.

The company's very thin TTM Net Margin of 2.5% and TTM FCF Margin of 0.4% are clear indicators of an industry where pricing flexibility is constrained, and profitability is highly dependent on effective cost management and operational efficiency, rather than the ability to command premium prices.